Aliases & Classifications for Mouth Disease

MalaCards integrated aliases for Mouth Disease:

Name: Mouth Disease 12 15
Mouth Diseases 44 73
Abnormality of the Mouth 29
Mouth Disorders 43

Classifications:



External Ids:

Disease Ontology 12 DOID:403
MeSH 44 D009059
NCIt 50 C27641 C3240
UMLS 73 C0026636

Summaries for Mouth Disease

MedlinePlus : 43 Your mouth is one of the most important parts of your body. It has many different functions. It allows you to Take in food and drink Breathe in air Start digestion, with your teeth chewing the food you eat and your salivary glands releasing saliva to help break down the food Speak and sing Show emotion, by smiling or pouting Any problem that affects your mouth can make it hard to eat, drink, or even smile. Some common mouth problems include Cold sores - painful sores on the lips and around the mouth, caused by a virus Canker sores - painful sores in the mouth, caused by bacteria or viruses Thrush - a yeast infection that causes white patches in your mouth Leukoplakia - white patches of excess cell growth on the cheeks, gums or tongue, common in smokers Dry mouth - a lack of enough saliva, caused by some medicines and certain diseases Gum or tooth problems Bad breath Treatment for mouth disorders varies, depending on the problem. If a mouth problem is caused by some other disease, treating that disease can help. It is also important to keep your mouth clean and healthy by brushing, flossing, and not using tobacco.

MalaCards based summary : Mouth Disease, also known as mouth diseases, is related to hand, foot and mouth disease and viral encephalitis, and has symptoms including coughing, halitosis and oral manifestations. An important gene associated with Mouth Disease is IL6 (Interleukin 6), and among its related pathways/superpathways are Innate Immune System and TGF-Beta Pathway. The drugs sodium fluoride and Triclosan have been mentioned in the context of this disorder. Affiliated tissues include the mouth, bone and salivary gland, and related phenotypes are cardiovascular system and hematopoietic system

Disease Ontology : 12 A gastrointestinal system disease that is located in the mouth.

Related Diseases for Mouth Disease

Diseases related to Mouth Disease via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 178)
# Related Disease Score Top Affiliating Genes
1 hand, foot and mouth disease 34.1 HMGB1 IFNG IL10 IL17F IL6 SCARB2
2 viral encephalitis 30.7 IL10 IL6 MX1
3 graft-versus-host disease 30.6 IFNG IL10 IL6
4 kawasaki disease 30.4 CRP IL10 IL6
5 meningitis 30.4 CRP IFNG IL10 IL6 TLR9
6 acute pancreatitis 30.4 CRP IL10 IL6
7 measles 30.4 IFNA1 IFNG IL6 STAT1
8 nervous system disease 30.4 IFNG IL10 IL6 TLR9
9 influenza 30.2 IFNA1 IFNG IRF3 MX1 TLR9
10 central nervous system disease 29.8 IFNG IL6 TLR9
11 cold agglutinin disease 11.1 CRP IL6
12 relapsing polychondritis 11.0 CRP IFNG IL6
13 intermediate uveitis 11.0 IFNG IL10 IL6
14 eales disease 11.0 IFNG IL10 IL6
15 hemorrhagic fever 11.0 IFNG IL10 IL6
16 acute pyelonephritis 11.0 CRP IL10 IL6
17 hematopoietic stem cell transplantation 11.0 IFNG IL10 IL6
18 cytomegalovirus infection 11.0 IFNG IL10 IL6
19 plasmodium vivax malaria 11.0 IFNG IL10 IL6
20 viral meningitis 11.0 CRP IFNG IL6
21 mixed lacrimal gland cancer 11.0 IL6 JAK1
22 campylobacteriosis 11.0 IFNG STAT1 VDR
23 leptospirosis 11.0 CRP IL10 IL6
24 paracoccidioidomycosis 11.0 IFNG IL10 IL6
25 lepromatous leprosy 11.0 IFNG IL10 VDR
26 prostatitis 11.0 IL10 IL6 VDR
27 pyelonephritis 11.0 CRP IL10 IL6
28 mixed connective tissue disease 11.0 IFNG IL10 IL6
29 echinococcosis 11.0 IFNG IL10 IL6
30 appendicitis 11.0 CRP IL10 IL6
31 hyperlucent lung 11.0 IFNG IL10
32 melioidosis 11.0 IFNG IL10 IL6
33 typhoid fever 11.0 CRP IFNG IL6
34 polyradiculoneuropathy 11.0 IFNG IL10 STAT1
35 rasmussen encephalitis 10.9 HMGB1 IFNG IL6
36 idiopathic neutropenia 10.9 HMGB1 IL10 IL6
37 tropical spastic paraparesis 10.9 IFNG IL10 IL6
38 temporal arteritis 10.9 CRP IFNG IL6
39 burning mouth syndrome 10.9
40 spondyloarthropathy 10.9 IFNG IL10 IL6
41 bronchiolitis obliterans 10.9 IFNG IL10 IL6
42 endocarditis 10.9 CRP IL10 IL6
43 eye lymphoma 10.9 IL10 IL6 TLR9
44 staphylococcal toxic shock syndrome 10.9 HMGB1 IFNG
45 multicentric castleman disease 10.9 CRP IFNG IL10 IL6
46 viral pneumonia 10.9 CRP IL6 TLR9
47 contact dermatitis 10.9 IFNG IL10 IL6
48 reactive arthritis 10.9 CRP IFNG IL10 IL6
49 central nervous system vasculitis 10.9 CRP IL6 TLR9
50 brucellosis 10.9 CRP IFNG IL10 IL6

Graphical network of the top 20 diseases related to Mouth Disease:



Diseases related to Mouth Disease

Symptoms & Phenotypes for Mouth Disease

UMLS symptoms related to Mouth Disease:


coughing, halitosis, oral manifestations, snoring, tinnitus, sore throat, vertigo/dizziness, equilibration disorder

MGI Mouse Phenotypes related to Mouth Disease:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 cardiovascular system MP:0005385 10.07 SCARB2 IL10 STAT1 IL6 BECN1 ITGAV
2 hematopoietic system MP:0005397 10.03 IL10 STAT1 IL17F IL6 TLR9 BECN1
3 homeostasis/metabolism MP:0005376 10 IL10 STAT1 IL6 TLR9 ATG12 IRF3
4 digestive/alimentary MP:0005381 9.92 IL10 STAT1 IL17F IL6 TLR9 ITGAV
5 immune system MP:0005387 9.77 STAT1 IL17F IL6 TLR9 IRF3 BECN1
6 renal/urinary system MP:0005367 9.17 SCARB2 TLR9 IL6 ITGAV JAK1 IFNG

Drugs & Therapeutics for Mouth Disease

Drugs for Mouth Disease (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 841)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1 sodium fluoride Approved Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 7681-49-4
2
Triclosan Approved, Investigational Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 3380-34-5 5564
3
Metronidazole Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 443-48-1 4173
4
Chlorhexidine Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 55-56-1 9552079 2713
5
Hyaluronic acid Approved, Vet_approved Phase 4,Phase 3,Phase 1,Phase 2,Not Applicable 9004-61-9 53477741
6
Amoxicillin Approved, Vet_approved Phase 4,Phase 2,Phase 3,Not Applicable 26787-78-0 33613
7
Epinephrine Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 51-43-4 5816
8
Racepinephrine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 329-65-7 838
9
Doxycycline Approved, Investigational, Vet_approved Phase 4,Phase 2,Phase 3,Not Applicable,Early Phase 1 564-25-0 54671203
10
Levonorgestrel Approved, Investigational Phase 4 797-63-7, 17489-40-6 13109
11
Estradiol Approved, Investigational, Vet_approved Phase 4 50-28-2 5757
12 Estradiol valerate Approved, Investigational, Vet_approved Phase 4 979-32-8
13
Ethinyl Estradiol Approved Phase 4 57-63-6 5991
14
Moxifloxacin Approved, Investigational Phase 4 354812-41-2, 151096-09-2 152946
15
Norgestimate Approved, Investigational Phase 4 35189-28-7 6540478
16
Polyestradiol phosphate Approved Phase 4 28014-46-2
17
Hexetidine Approved, Investigational Phase 4 141-94-6
18
Miconazole Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 22916-47-8 4189
19
Acetaminophen Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 103-90-2 1983
20
Aminocaproic Acid Approved, Investigational Phase 4,Phase 3 60-32-2 564
21
Lidocaine Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1,Not Applicable 137-58-6 3676
22
Nystatin Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1,Not Applicable 1400-61-9 11953884
23
Methylprednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 83-43-2 6741
24
Prednisolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Not Applicable 50-24-8 5755
25
Fluocinolone Acetonide Approved, Investigational, Vet_approved Phase 4,Not Applicable 67-73-2 6215
26
Calcium Carbonate Approved, Investigational Phase 4,Not Applicable 471-34-1
27
Cyclophosphamide Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1 50-18-0, 6055-19-2 2907
28
Prednisone Approved, Vet_approved Phase 4,Phase 2,Not Applicable 53-03-2 5865
29
Acyclovir Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 59277-89-3 2022
30
Docosanol Approved, Investigational Phase 4 30303-65-2, 661-19-8 12620
31
Fluticasone Approved, Experimental, Investigational Phase 4 90566-53-3 62924
32
Menthol Approved Phase 4,Phase 3,Phase 2,Not Applicable,Early Phase 1 2216-51-5 16666
33
Edetic Acid Approved, Vet_approved Phase 4,Phase 3,Not Applicable 60-00-4, 62-33-9 6049
34
Pentetic acid Approved Phase 4,Phase 3,Not Applicable 67-43-6
35
Simvastatin Approved Phase 4,Phase 2,Phase 3,Not Applicable 79902-63-9 54454
36
Metformin Approved Phase 4,Phase 2,Phase 3 657-24-9 14219 4091
37
Minocycline Approved, Investigational Phase 4,Phase 3,Phase 1,Not Applicable 10118-90-8 5281021
38
Azithromycin Approved Phase 4,Phase 2,Not Applicable 83905-01-5 55185 447043
39
Ciprofloxacin Approved, Investigational Phase 4,Phase 3,Phase 1,Not Applicable 85721-33-1 2764
40
Zinc Approved, Investigational Phase 4,Phase 3,Phase 2,Not Applicable,Early Phase 1 7440-66-6 23994
41
Ethanol Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 64-17-5 702
42
Cetylpyridinium Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 7773-52-6
43
Dexamethasone Approved, Investigational, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Early Phase 1,Not Applicable 50-02-2 5743
44
Benzocaine Approved, Investigational Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 1994-09-7, 94-09-7 2337
45
Triamcinolone Approved, Vet_approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable,Early Phase 1 124-94-7 31307
46
Pimecrolimus Approved, Investigational Phase 4,Phase 3,Phase 2 137071-32-0 6447131 17753757
47
Tacrolimus Approved, Investigational Phase 4,Phase 2,Not Applicable 104987-11-3 445643 439492
48
Dopamine Approved Phase 4,Phase 2,Phase 3,Phase 1,Not Applicable 51-61-6, 62-31-7 681
49
Ibuprofen Approved Phase 4,Phase 2,Phase 3,Not Applicable 15687-27-1 3672
50
Ephedrine Approved Phase 4,Phase 3,Phase 2,Phase 1,Not Applicable 299-42-3 9294

Interventional clinical trials:

(show top 50) (show all 2617)
# Name Status NCT ID Phase Drugs
1 The Efficacy of Cyanoacrylate Adhesive (PeriAcryl®90 HV) in Periodontal Wound Healing Unknown status NCT02826109 Phase 4
2 Clinical Investigation of the Effects of Colgate Total Toothpaste as Compared to a Matching Placebo on Periodontal Disease and Systemic Inflammatory Markers Unknown status NCT02670135 Phase 4 Triclosan Containing Toothpaste;Triclosan Free Toothpaste
3 The Treatment of Periodontal Diseases Unknown status NCT01318928 Phase 4 Metronidazol
4 Effect of Actonel on Periodontal Health of Postmenopausal Women Unknown status NCT00594334 Phase 4 Risedronate
5 Efficacy and Safety of a Commercially Available Injectable Hyaluronic Acid Dental Filler for Periodontal Pockets Unknown status NCT02391974 Phase 4
6 Manually Versus Digitally Fabricated Removable Partial Dentures Unknown status NCT01191073 Phase 4
7 Metronidazole and Amoxicillin for the Treatment of Type 2 Diabetic Subjects With Periodontitis Unknown status NCT02135952 Phase 4 MTZ+AMX
8 Clinical, Microbiological and Biochemical Effects of the Antimicrobial Photodynamic Therapy Unknown status NCT01532674 Phase 4
9 Clinical and Microbiological Effects of an Essential Oils Solution Used as an Adjunct to Daily Oral Hygiene Practices in Chronic Periodontitis Patients in Supportive Care Unknown status NCT01195493 Phase 4
10 Study of Scaling and Root Planing With PerioWave Versus Scaling and Root Planing Alone in Chronic Periodontitis Unknown status NCT00297531 Phase 4
11 SRP in Combination With PERIOWAVE in Comparison to SRP Alone in Chronic Periodontitis Unknown status NCT00296881 Phase 4
12 Norplant and Irregular Bleeding/Spotting Unknown status NCT00064766 Phase 4 doxycycline
13 Efficacy of Three Antibiotic Protocols for Aggressive Periodontitis Treatment Unknown status NCT02839421 Phase 4 Scaling and Root Planing combined with moxifloxacin
14 Evaluation of a Lateral Window Technique Augmentation for Maxillary Sinus Using Ultrasound Activated Pins Unknown status NCT02449707 Phase 4
15 Methodology Antiseptic Application, Influence on Oral Biofilm. Unknown status NCT02267239 Phase 4 essential oils, immersion;Chlorhexidine, immersion;essential oils, mouthwash;chlorhexidine, mouthwash
16 Effect of Probiotic Lozenges on Halitosis in Patients With Chronic Periodontitis Unknown status NCT02789436 Phase 4 L. reuteri Prodentis® lozenges
17 Randomized Clinical Trial With Aminocaproic Acid in the Prevention of Exodontic Bleeding in Anticoagulants Patients Unknown status NCT02238288 Phase 4 Aminocaproic acid;lidocaine and epinephrine;Paracetamol
18 Pinhole Surgical Technique With And Without Use Of Buttons For Treatment Of Multiple Gingival Recessions: RCT Unknown status NCT02632968 Phase 4
19 Laser De-epithelialization for Epithelial Exclusion in Root Coverage Procedure: a Clinical Study Unknown status NCT02626117 Phase 4
20 Platelet Rich Fibrin in the Treatment of Palatal Wounds Unknown status NCT02438046 Phase 4
21 Oral Hygiene Regimen in Patients on HCT Unknown status NCT02662374 Phase 4 .02% Chlorohexidine Gluconate;3% Sodium Bicarbonate;Nystatin 10000U/ml;Supersaturated Calcium Phosphate
22 Connective Tissue Graft Versus Mucograft Collagen Matrix for Coverage of Multiple Gingival Recession Defects Unknown status NCT01440426 Phase 4
23 Effectiveness of Low Energy Laser Treatment in Oral Mucositis Induced by Chemotherapy and Radiotherapy in Head and Neck Cancer Unknown status NCT01876407 Phase 4
24 Adhesion of Connective Tissue Around Laser-treated Abutments for Dental Implants - Clinical Trial in Humans Unknown status NCT01954485 Phase 4
25 Anticaries Effect of Probiotic Lactobacillus Brevis CD2 (Lb CD2). Unknown status NCT01778699 Phase 4
26 The Efficacy of Methylprednisolone in the Treatment of Patients With Ocular Involvement in Behcet's Disease Unknown status NCT01306955 Phase 4 methylorednisolone
27 Flucinolone Acetonide Implant for Treating Refractory Ocular Behcet's Disease Unknown status NCT00720928 Phase 4 flucinolone acetonide
28 Cyclosporine A in the TReatment of Interstitial Pneumonitis Associated With Sjogren's Syndrome Unknown status NCT02370550 Phase 4 Cyclosporin A;Prednisone;Placebo;Calcium carbonate D
29 Stereotactic Body Radiotherapy for Head and Neck Tumors Unknown status NCT01344356 Phase 4
30 Safety and Efficacy of Anti-Pandemic H1N1 Vaccination in Rheumatic Diseases Unknown status NCT01151644 Phase 4
31 Sex Steroids in Sjögren's Syndrome: Effect of Substitution Treatment on Fatigue Unknown status NCT00543166 Phase 4 dehydroepiandrosterone
32 Comparison of Topical Antiviral Agents for Labial Cold Sores (Herpes Labialis) Unknown status NCT00467662 Phase 4 Acyclovir 5%;Docosanol 10%
33 Study to Assess the Incidence of Local Oropharyngeal and Laryngeal Adverse Effects of Advair DISKUS 250/50 Mcg BID Unknown status NCT00235053 Phase 4 fluticasone/salmeterol DISKUS 250/50
34 Regenerative Surgical Treatment of Peri-implantitis Completed NCT02500654 Phase 4
35 Melatonin as an Adjunctive Therapy for Chronic Periodontitis. Completed NCT03368430 Phase 4 Placebo
36 Locally Delivered Doxycycline Adjunct to Nonsurgical Periodontal Therapy. Completed NCT02487186 Phase 4 Doxicicline
37 EMD and/or Bone Substitute for the Treatment of Class II Furcations Completed NCT02474498 Phase 4 EMD
38 Effectiveness of Hygiene Solutions on Denture Biofilm Completed NCT02407834 Phase 4
39 Conventional or Minimally Invasive Surgical Technique for the Treatment of Furcation Defects Using Enamel Matrix Derivative and Anorganic Bovine Bone - a Randomized Controlled Clinical Trial. Completed NCT02102360 Phase 4
40 Pediatric Study to Access Pharmacokinetics and Safety of Oraqix Gel Completed NCT01591616 Phase 4 lidocaine and prilocaine
41 Photodynamic Therapy During Supportive Periodontal Therapy Completed NCT02666573 Phase 4
42 The Laryngeal Mask Airway in Edentulous Geriatric Patients Completed NCT02197377 Phase 4
43 Evaluation of Antimicrobial Photodynamic Therapy in Multiple Applications as a Coadjuvant in the Surgical Therapy of Access to Scaling Completed NCT03498404 Phase 4
44 Simvastatin Gel With Perforated Resorbable Membranes in Treatment of Intrabony Defects in Chronic Periodontitis Completed NCT03419429 Phase 4 Simvastatin
45 Locally Delivered 1% Metformin Gel in Peri-implantitis Completed NCT03312582 Phase 4 1% local metformin gel
46 Evaluation of the Efficacy of 0.8% Hyaluronic Acid Gel Completed NCT03311906 Phase 4 0.8% Hyaluronic Acid
47 Effect of Hyaluronic Acid on Perimplantitis Completed NCT03157193 Phase 4 Hyaluronic Acid;Hydroxypropyl Guar
48 Implant Healing Abutment and Chlorhexidine Completed NCT03142828 Phase 4 Chlorhexidine
49 Effect of Arthrospira Platensis (Spirulina) as an Adjunct to Scaling and Root Planing on Salivary Antioxidant Levels in Chronic Periodontitis Subjects Completed NCT02886676 Phase 4 Spirulina capsules
50 Treatment of Chronic Periodontitis With Repeated Adjunctive Antimicrobial Photodynamic Therapy Completed NCT02734784 Phase 4

Search NIH Clinical Center for Mouth Disease

Inferred drug relations via UMLS 73 / NDF-RT 51 :


Cochrane evidence based reviews: mouth diseases

Genetic Tests for Mouth Disease

Genetic tests related to Mouth Disease:

# Genetic test Affiliating Genes
1 Abnormality of the Mouth 29

Anatomical Context for Mouth Disease

The Foundational Model of Anatomy Ontology organs/tissues related to Mouth Disease:

19
The Mouth

MalaCards organs/tissues related to Mouth Disease:

41
Bone, Salivary Gland, Eye, Tongue, Testes, Kidney, Lung

Publications for Mouth Disease

Articles related to Mouth Disease:

(show top 50) (show all 964)
# Title Authors Year
1
Foot-and-mouth disease virus nonstructural protein 2B interacts with cyclophilin A, modulating virus replication. ( 29906248 )
2018
2
Foot and mouth disease vaccine strain selection: Current approaches and future perspectives. ( 29950121 )
2018
3
Use of ENABLAr adjuvant to increase the potency of an adenovirus-vectored foot-and-mouth disease virus serotype A subunit vaccine. ( 29358056 )
2018
4
Development of a rapid test for detection of foot-and-mouth disease virus specific antibodies using gold nanoparticles. ( 29911152 )
2018
5
Epidemiological and serological surveillance of hand-foot-and-mouth disease in Shanghai, China, 2012-2016. ( 29362406 )
2018
6
Clinical profile and virology analysis of hand, foot and mouth disease cases from North Kerala, India in 2015-2016: A tertiary care hospital-based cross-sectional study. ( 29620046 )
2018
7
A spatiotemporal mixed model to assess the influence of environmental and socioeconomic factors on the incidence of hand, foot and mouth disease. ( 29463224 )
2018
8
An assessment of a pediatric early warning system score in severe hand-foot-and-mouth disease children: To detect clinical deterioration in hospitalized children. ( 29953028 )
2018
9
A partial deletion within foot-and-mouth disease virus non-structural protein 3A causes clinical attenuation in cattle but does not prevent subclinical infection. ( 29346074 )
2018
10
Cytokine and Chemokine Profiling in Patients with Hand, Foot and Mouth Disease in Singapore and Malaysia. ( 29511232 )
2018
11
Classical Hand, Foot and Mouth Disease Replaced by Atypical Hand, Foot and Mouth Disease. ( 29507995 )
2018
12
Gene expression analysis of porcine whole blood cells infected with foot-and-mouth disease virus using high-throughput sequencing technology. ( 29979724 )
2018
13
Modifications to the foot-and-mouth disease virus 2A peptide; influence on polyprotein processing and virus replication. ( 29386286 )
2018
14
Single-cell analysis of the impact of host-cell heterogeneity on infection with foot and mouth disease virus. ( 29444939 )
2018
15
Foot-and-Mouth Disease Virus Counteracts on Internal Ribosome Entry Site Suppression by G3BP1 and Inhibits G3BP1-Mediated Stress Granule Assembly <i>via</i> Post-Translational Mechanisms. ( 29887867 )
2018
16
Molecular epidemiology, evolution and phylogeny of foot-and-mouth disease virus. ( 29412184 )
2018
17
An improved, rapid competitive ELISA using a novel conserved 3B epitope for the detection of serum antibodies to foot-and-mouth disease virus. ( 29916768 )
2018
18
Identification of two novel foot-and-mouth disease virus cytotoxic T lymphocyte epitopes that can bind six SLA-I proteins. ( 29432828 )
2018
19
Emerging Coxsackievirus A6 Causing Hand, Foot and Mouth Disease, Vietnam. ( 29553326 )
2018
20
Different responses of weather factors on hand, foot and mouth disease in three different climate areas of Gansu, China. ( 29310596 )
2018
21
Complete Genome Sequences of Five Foot-and-Mouth Disease Viruses of Serotype A Isolated from Cattle in Nigeria between 2013 and 2015. ( 29449384 )
2018
22
The dynamics of the hand, foot and mouth disease epidemic from 2008 to 2016 in Zhenjiang city, China. ( 29634358 )
2018
23
Development of a chemiluminescence immunoassay using recombinant non-structural epitope-based proteins to accurately differentiate foot-and-mouth disease virus-infected and vaccinated bovines. ( 29341485 )
2018
24
An improved reverse transcription loop-mediated isothermal amplification assay for sensitive and specific detection of serotype O foot-and-mouth disease virus. ( 29964077 )
2018
25
Epidemiological Characteristics and Spatial-Temporal Distribution of Hand, Foot, and Mouth Disease in Chongqing, China, 2009-2016. ( 29401726 )
2018
26
Epidemiological surveillance of hand, foot and mouth disease in Shanghai in 2014-2016, prior to the introduction of the enterovirus 71 vaccine. ( 29559626 )
2018
27
Rapid detection of hand, foot and mouth disease enterovirus genotypes by multiplex PCR. ( 29758237 )
2018
28
Development and validation of a foot-and-mouth disease virus SAT serotype-specific 3ABC assay to differentiate infected from vaccinated animals. ( 29428400 )
2018
29
Hand, Foot and Mouth Disease and Echovirus 3: A Comment to HA,gsberg &amp;amp; Bygum. ( 29651498 )
2018
30
Correlation analysis on serum inflammatory cytokine level and neurogenic pulmonary edema for children with severe hand-foot-mouth disease. ( 29724230 )
2018
31
An evaluation of Chloroquine as a broad-acting antiviral against Hand, Foot and Mouth Disease. ( 29175128 )
2018
32
Overview of foot-and-mouth disease awareness among farmers and veterinarians in France. ( 29907659 )
2018
33
Gianotti-Crosti syndrome and atypical hand-foot-mouth disease: two distinct entities or two manifestation of the same infection? ( 29963801 )
2018
34
Quantifying the influence of temperature on hand, foot and mouth disease incidence in Wuhan, Central China. ( 29386630 )
2018
35
Innate immune sensor LGP2 is cleaved by the Leader protease of foot-and-mouth disease virus. ( 29958302 )
2018
36
Stakeholder perceptions of foot-and-mouth disease control in South Africa. ( 29891144 )
2018
37
Correction to: Correlation analysis on serum inflammatory cytokine level and neurogenic pulmonary edema for children with severe hand-foot-mouth disease. ( 29907161 )
2018
38
Full-Genome Sequence of an Enterovirus 71 Strain Isolated from a Throat Swab from a Child with Severe Hand-Foot-and-Mouth Disease in Changzhou, China, in 2017. ( 29371346 )
2018
39
Hand-foot-mouth disease and use of steroids, intravenous immunoglobulin, and traditional Chinese herbs in a tertiary hospital in Shantou, China. ( 29925360 )
2018
40
Genetic stability of foot-and-mouth disease virus during long-term infections in natural hosts. ( 29390015 )
2018
41
Severity and burden of hand, foot and mouth disease in Asia: a modelling study. ( 29564154 )
2018
42
Evaluation of environmental sampling as a low technology method for surveillance of Foot-and-mouth disease virus in an endemic area. ( 29959244 )
2018
43
Hand, Foot and Mouth Disease in the Andaman Islands, India. ( 29845955 )
2018
44
Hand, foot and mouth disease: current knowledge on clinical manifestations, epidemiology, aetiology and prevention. ( 29411190 )
2018
45
Parental perspectives on hand, foot, and mouth disease among children in Hong Kong: a longitudinal study. ( 29386079 )
2018
46
Impact of PM<sub>10</sub> and meteorological factors on the incidence of hand, foot, and mouth disease in female children in Ningbo, China: a spatiotemporal and time-series study. ( 29961907 )
2018
47
Identification of recombinant coxsackievirus A6 variants in hand, foot and mouth disease in Nanjing, China, 2013. ( 29947601 )
2018
48
Molecular epidemiology of coxsackievirus A6 derived from hand, foot, and mouth disease in Fukuoka between 2013 and 2017. ( 29981169 )
2018
49
Hand, foot and mouth disease in an adult. ( 29372548 )
2018
50
Impact of meteorological factors on the incidence of childhood hand, foot, and mouth disease (HFMD) analyzed by DLNMs-based time series approach. ( 29391070 )
2018